Moderna to Host Investor Event - Science Day
-
No split loyalties for US star 'Jedi' Robinson
-
Czechs eye World Cup liftoff against South Africa
-
Lula jokes he is thinking of 'signing Messi' for Brazil
-
Ronaldo makes history before England enter World Cup fray
-
No.1 Scheffler chases US Open win and career Slam at windy Shinnecock
-
Rose: reduced green speeds vital as US Open winds howl
-
Ronaldo fails to shine as DR Congo earn historic World Cup point
-
US Olympic athlete Simpson receiving treatment after 'medical incident'
-
Cuba's communists meet to fast-track liberal reforms
-
Gakpo says Christian prayer group unites Dutch World Cup squad
-
US Federal Reserve holds rates steady, raises inflation expectations
-
USGA will water greens between waves at US Open
-
Brest boss Roy dies aged 58 from cancer
-
Badosa beats Gauff in Berlin to end losing run
-
Marseille dodge European expulsion but hit with UEFA fine
-
Blundell, Phillips lead New Zealand recovery against England
-
'Elegant' Ombudsman's princely performance lights up Royal Ascot
-
Golf groups delay ball distance limit rollback to 2030
-
Military salutes and K-pop madness shake up Colombia campaigning
-
Ex-OPEC president Diezani Alison-Madueke cleared of bribery in UK trial
-
Trump says Iran accord to be signed 'shortly', 'maybe' Thursday or Friday
-
Malawians crowd makeshift S.African camp desperate to get home
-
Mandhana stars in India rout of Netherlands at Women's T20 World Cup
-
W marks the X-spot: European social network takes on Musk
-
Recovery of ship traffic in Hormuz limited, but signs emerge
-
England's World Cup opener puts Spanish resort on beer alert
-
Gauff crumbles in early Berlin exit against Badosa
-
Gill, Kishan star as India thrash Afghanistan to clinch ODI series
-
Farrell names uncapped Connacht trio in Ireland's Nations squad
-
US teen gets look at idols as youngest player at US Open
-
Nations allege 'attacks' on science at key climate talks
-
Pogacar crushes rivals on opening Tour of Switzerland stage
-
Oil higher, stocks steady as US-Iran peace talks approach
-
Baker strikes on England debut before New Zealand fight back
-
Plague was killing hunter-gatherers 5,500 years ago: study
-
Feyenoord sign Van Bronckhorst as new coach
-
De Minaur races into Queen's Club quarter-finals
-
Borthwick plans to rest Itoje for England tour
-
Cuba's under-pressure communists meets to fast-track liberal reforms
-
Golf governing bodies and tours to study distance limit options
-
Prince Harry and family to visit UK in July: media
-
Barbarians pick Vakatawa for South Africa match
-
What happens when the Strait of Hormuz re-opens?
-
Belgian driver gets 27-year jail term for deadly carnival crash
-
Leafs hire Hiller as head coach ahead of NHL draft top pick
-
Russia says Ukraine drone hit bus carrying Belarusian children
-
US retail sales beat expectations in May as energy costs stay high
-
Trump halts intel chief confirmation, renews vote curb demand
-
Connolly leads Australia to four-wicket win over Bangladesh in T20 opener
-
England's Fisher and Archer strike against New Zealand after Stokes saga
Moderna to Host Investor Event - Science Day
CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.
The event will feature an overview of Moderna's research and early development programs, highlighting how the Company's mRNA platform, together with advances in AI and robotics, is accelerating innovation and creating opportunities to expand into new therapeutic areas.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
M.Thompson--AMWN
